These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 29176327

  • 1. Hyperkalemia Associated with Renin-Angiotensin-Aldosterone System Inhibition in Patients with Heart Failure; Underexplored and Overrated?
    Koratala A, Aboud H, Kazory A.
    Nephron; 2018; 138(3):220-221. PubMed ID: 29176327
    [No Abstract] [Full Text] [Related]

  • 2. Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure.
    McCullough PA, Rangaswami J.
    Nephron; 2018; 138(3):173-175. PubMed ID: 29207385
    [No Abstract] [Full Text] [Related]

  • 3. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR, Bakris GL, Gross C, Mayo MR, Garza D, Stasiv Y, Yuan J, Berman L, Williams GH.
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [Abstract] [Full Text] [Related]

  • 4. Prevention and management of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors.
    Weinstein J, Girard LP, Lepage S, McKelvie RS, Tennankore K.
    CMAJ; 2021 Dec 06; 193(48):E1836-E1841. PubMed ID: 34872955
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Hyperkalemia in Heart Failure.
    DeFilippis EM, Desai AS.
    Curr Heart Fail Rep; 2017 Aug 06; 14(4):266-274. PubMed ID: 28656517
    [Abstract] [Full Text] [Related]

  • 6. PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.
    Buysse JM, Huang IZ, Pitt B.
    Future Cardiol; 2012 Jan 06; 8(1):17-28. PubMed ID: 22185443
    [Abstract] [Full Text] [Related]

  • 7. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 06; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 8. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.
    Beusekamp JC, Tromp J, Cleland JGF, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Ouwerkerk W, van Veldhuisen DJ, Voors AA, van der Meer P.
    JACC Heart Fail; 2019 Nov 06; 7(11):970-979. PubMed ID: 31606364
    [Abstract] [Full Text] [Related]

  • 9. Hyperkalemia: a threat to RAAS inhibition?
    Schrier RW.
    Nat Rev Nephrol; 2010 May 06; 6(5):245-6. PubMed ID: 20424624
    [No Abstract] [Full Text] [Related]

  • 10. Hyperkalemia risk and treatment of heart failure.
    Segura J, Ruilope LM.
    Heart Fail Clin; 2008 Oct 06; 4(4):455-64. PubMed ID: 18760757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
    Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.
    Clin J Am Soc Nephrol; 2009 Mar 06; 4(3):542-51. PubMed ID: 19261819
    [Abstract] [Full Text] [Related]

  • 14. Role of Hyperkalemia in Heart Failure and the Therapeutic Use of Potassium Binders.
    Sarwar CMS, Bhagat AA, Anker SD, Butler J.
    Handb Exp Pharmacol; 2017 Mar 06; 243():537-560. PubMed ID: 28382468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
    Pitt B.
    Curr Heart Fail Rep; 2009 Jun 06; 6(2):112-6. PubMed ID: 19486595
    [Abstract] [Full Text] [Related]

  • 18. Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Bots SH, den Ruijter HM.
    Circulation; 2019 Mar 19; 139(12):1469-1471. PubMed ID: 30883224
    [No Abstract] [Full Text] [Related]

  • 19. Repeated subileus due to angioedema during renin-angiotensin system blockade.
    Tojo A, Onozato ML, Fujita T.
    Am J Med Sci; 2006 Jul 19; 332(1):36-8. PubMed ID: 16845240
    [Abstract] [Full Text] [Related]

  • 20. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA, Gales MA.
    Ann Pharmacother; 2016 Jun 19; 50(6):502-10. PubMed ID: 27009290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.